Info

Final Surge Podcast

In the Final Surge Podcast, we interview coaches, athletes authors, and endurance industry experts to help you train with a purpose.
RSS Feed
Final Surge Podcast
2020
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June


All Episodes
Archives
Now displaying: Page 1
Nov 7, 2019

Episode 142: This week we welcome Mario Fraioli to the podcast we talk about the recent Chicago and NYC marathons, the sub 1:59 marathon and what this all tells us about the upcoming Olympic Trials. We also discuss the shoes. How much do they help and what should be the limits. Please share the podcast with your friends.

1:08 Were there any big surprises or take-a-ways you had from the NYC marathon results?

2:59 Desi went out early, did that surprise you?

5:50 How did your NYC Marathon go?

6:15 Chicago on the men's side we had 10 under 2:12

7:54 Jared Ward had a great NYC race too

8:32 On the women's side of Chicago do you think that 2:14 was real?

10:47 We have so many distance runners getting popped for drugs, you almost need to ask yourself why they are still doing it

12:39 What did you think of the 1:59 marathon?

17:24 Looking at the US Trials we have twice as many men and women qualified, why? Is it because of the shoes?

19:55 The new shoes, how much do they make a difference?

23:20 Is there an advantage to Nike athletes?

25:53 Should there be some sort of technology limits we allow?

29:23 The US Marathon Trials course is hilly, who is this going to help?

33:00 On the women's side is there anyone a lock for the team?

35:50 So what are you up to with the Morning Shakeout Newsletter and Podcast?

 

Resources
Morning Shakeout
Mario on Instagram
Mario on Twitter
Mario's Website

0 Comments
Adding comments is not available at this time.